company background image
3681

SinoMab BioScience SEHK:3681 Stock Report

Last Price

HK$1.83

Market Cap

HK$1.9b

7D

-4.2%

1Y

-42.6%

Updated

28 Nov, 2022

Data

Company Financials
3681 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

3681 Stock Overview

SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics.

SinoMab BioScience Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SinoMab BioScience
Historical stock prices
Current Share PriceHK$1.83
52 Week HighHK$3.19
52 Week LowHK$0.83
Beta0.58
1 Month Change1.67%
3 Month Change-1.08%
1 Year Change-42.63%
3 Year Change-54.82%
5 Year Changen/a
Change since IPO-69.50%

Recent News & Updates

Recent updates

Update: SinoMab BioScience (HKG:3681) Stock Gained 21% In The Last Year

Mar 04
Update: SinoMab BioScience (HKG:3681) Stock Gained 21% In The Last Year

What You Need To Know About SinoMab BioScience Limited's (HKG:3681) Investor Composition

Jan 28
What You Need To Know About SinoMab BioScience Limited's (HKG:3681) Investor Composition

Did SinoMab BioScience Limited (HKG:3681) Insiders Buy Up More Shares?

Jan 01
Did SinoMab BioScience Limited (HKG:3681) Insiders Buy Up More Shares?

Loss-Making SinoMab BioScience Limited (HKG:3681) Expected To Breakeven In The Medium-Term

Nov 30
Loss-Making SinoMab BioScience Limited (HKG:3681) Expected To Breakeven In The Medium-Term

Shareholder Returns

3681HK BiotechsHK Market
7D-4.2%-9.4%-0.2%
1Y-42.6%-52.0%-24.6%

Return vs Industry: 3681 exceeded the Hong Kong Biotechs industry which returned -52% over the past year.

Return vs Market: 3681 underperformed the Hong Kong Market which returned -24.6% over the past year.

Price Volatility

Is 3681's price volatile compared to industry and market?
3681 volatility
3681 Average Weekly Movement5.0%
Biotechs Industry Average Movement11.3%
Market Average Movement8.0%
10% most volatile stocks in HK Market15.0%
10% least volatile stocks in HK Market3.9%

Stable Share Price: 3681 is less volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: 3681's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001296Shawn Leunghttps://www.sinomab.com

SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA), as well as in various clinical stages for other immunological diseases, such as systemic lupus erythematosus (SLE), Sjogren’s syndrome (SS), and non-Hodgkin's lymphoma (NHL). The company also focuses on developing SN1011, a Bruton’s tyrosine kinase inhibitor, which is in Phase II clinical trial for the treatment of pemphigus, as well as in phase 1 clinical trial to treat multiple sclerosis, SLE, and NMOSD.

SinoMab BioScience Limited Fundamentals Summary

How do SinoMab BioScience's earnings and revenue compare to its market cap?
3681 fundamental statistics
Market CapHK$1.91b
Earnings (TTM)-HK$346.19m
Revenue (TTM)HK$29.06m

65.2x

P/S Ratio

-5.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
3681 income statement (TTM)
RevenueCN¥26.66m
Cost of RevenueCN¥0
Gross ProfitCN¥26.66m
Other ExpensesCN¥344.24m
Earnings-CN¥317.58m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.31
Gross Margin100.00%
Net Profit Margin-1,191.36%
Debt/Equity Ratio39.7%

How did 3681 perform over the long term?

See historical performance and comparison